FDA UNTITLED_LETTER - Hallandale Pharmacy - September 29, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Hallandale Pharmacy, with an inspection on September 29, 2020, covering drugs.

Company: Hallandale Pharmacy
Inspection Date: September 29, 2020
Product Type: Drugs
Person: Monica R. Maxwell (Program Division Director)

Open in Dashboard

ID · a989e914-77c1-425b-8a0c-092cf451626b

Violation Codes10

FD&C Act 501(a)(2)(B)21 U.S.C. 331(k)21 CFR 21121 U.S.C. 351(a)(2)(A)21 CFR 21021 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)FD&C Act 505FD&C Act 501(a)(2)(A)FD&C Act 502(f)(1)

Full citation text and observation details available on the Dashboard.